Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-040548
Filing Date
2013-07-18
Accepted
2013-07-18 14:56:18
Documents
1
Period of Report
2013-07-18

Document Format Files

Seq Description Document Type Size
1 rrd385753.html 4  
1 rrd385753.xml 4 4167
  Complete submission text file 0001181431-13-040548.txt   5440
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13974724

Mailing Address 707 STATE ROAD NEW JERSEY NJ 08540
Business Address 707 STATE ROAD NEW JERSEY NJ 08540 908-741-4323
Omthera Pharmaceuticals, Inc. (Issuer) CIK: 0001477598 (see all company filings)

EIN.: 263797738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations